Impact of new therapeutics for hepatitis C virus infection in incarcerated populations

Spaulding AS, Kim AY, Harzke AJo, et al. Impact of new therapeutics for hepatitis C virus infection in incarcerated populations. Sullivan JC, Linas BP, Brewer A, Dickert J, McGovern BH, Strick LB, et al. Top Antivir Med. 2013;21(1):27-35.

Publication Type:

Journal Article

Authors:

Spaulding, Anne S.; Kim, Arthur Y.; Harzke, Amy Jo; et, al

Source:

Top Antivir Med, Volume 21, Issue 1, p.27-35 (2013)

Keywords:

Antiviral Agents, Cost-Benefit Analysis, Drug Therapy, Combination, Hepatitis C, Chronic, Humans, Infection Control, Mass Screening, Models, Theoretical, Prisoners

Cited On:

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/23596276

Export Citation:
RIS Format
Top